Gary Lu is an Oncology physician. OpenAlex indexes 106 publications with 2,159 citations (h-index 25).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2600 Scripture St
Denton, TX 762014315
Telephone
940-382-1022Provider last certified this registry record 24 May 2022.
Industry payments
45 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year202522 payments
- Incyte CorporationProgram year20259 payments
- Janssen Biotech, Inc.Program year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
45.1%Erythropoiesis-stimulating Agent24.1%Darbepoetin alfa100%Part B, office-administered≥25 patientsParenteral Iron Replacement18.7%Iron sucrose100%Part B, office-administered≥36 patients+ 2 more classes in this area
Cancer & immunology
24.1%PD-1 inhibitor22.4%Pembrolizumab100%Part B, office-administered≥20 patientsNucleoside Metabolic Inhibitor1.1%Fluorouracil100%Part B, office-administered≥18 patients+ 7 more classes in this area
Metabolism & gastrointestinal
18.9%Other antiemetics15%Fosaprepitant100%Part B, office-administered≥22 patientsSerotonin-3 Receptor Antagonist3.1%Palonosetron hcl60%Granisetron hydrochloride38%Ondansetron Hcl1%Ondansetron Odt1%Part D + Part B≥38 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Percutaneous hepatic injection of rose bengal disodium (PV-10) in metastatic uveal melanoma.
Journal of Clinical Oncology
2020 - A machine learning based approach to identify protected health information in Chinese clinical text
International Journal of Medical Informatics
2018 - Healthcare-Related Qigong for the Prevention of Lifestyle-Related Diseases
OBM Integrative and Complementary Medicine
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”